{"id":"NCT02082262","sponsor":"Allergan","briefTitle":"AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-03","primaryCompletion":"2014-07","completion":"2014-07","firstPosted":"2014-03-10","resultsPosted":"2015-10-08","lastUpdate":"2016-03-14"},"enrollment":140,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Conjunctivitis, Allergic"],"interventions":[{"type":"DRUG","name":"AGN-229666","otherNames":[]}],"arms":[{"label":"AGN-229666","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the safety and efficacy of AGN-229666 for the treatment of seasonal or perennial allergic conjunctivitis.","primaryOutcome":{"measure":"Change From Baseline In Ocular Itching Frequency Score Using a 6-point Scale","timeFrame":"Baseline, Day 70","effectByArm":[{"arm":"AGN-229666","deltaMin":4.4,"sd":0.49}],"pValues":[]},"eligibility":{"minAge":"10 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":140},"commonTop":["Conjunctival Hyperaemia","Eye Pruritus","Somnolence","Eye Discharge","Instillation Site Irritation"]}}